Iterum Therapeutics PLC (ITRM) Reports Q2 Loss, Misses Revenue Estimates

Original post

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Iterum Therapeutics PLC (ITRM): Free Stock Analysis Report
 
To read this article on Zacks.com click here.